Effect of dopamine therapy on nonverbal affect burst recognition in Parkinson's disease

PLoS ONE

Volumn 9, Issue 3, 2014, Pages

  Péron, Julie ^a   Grandjean, Didier ^a   Drapier, Sophie ^b,c   Vérin, Marc ^b,c  

^a UNIVERSITY OF GENEVA   (Switzerland)

^b UNIVERSITÉ DE RENNES 1   (France)

^c PONTCHAILLOU UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

LEVODOPA; PRAMIPEXOLE; ROPINIROLE; DOPAMINE;

ADULT; AFFECT; ANGER; ARTICLE; BASAL GANGLION; CLINICAL ARTICLE; CONTROLLED STUDY; DISGUST; DRUG EFFECT; EMOTION; FEAR; FEMALE; HUMAN; MALE; NEUROPSYCHOLOGICAL TEST; NONVERBAL AFFECT BURST; PARKINSON DISEASE; PSYCHOLOGIC ASSESSMENT; RECOGNITION; SCREENING; VISUAL ANALOG SCALE; CASE CONTROL STUDY; DEMOGRAPHY; DRUG EFFECTS; MIDDLE AGED; PSYCHOLOGY; TASK PERFORMANCE;

CASE-CONTROL STUDIES; DEMOGRAPHY; DOPAMINE; EMOTIONS; FEMALE; HUMANS; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; PARKINSON DISEASE; RECOGNITION (PSYCHOLOGY); TASK PERFORMANCE AND ANALYSIS;

EID: 84907866916     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0090092     Document Type: Article

References (48)

1. Grandjean D, Banziger T, Scherer KR (2006) Intonation as an interface between language and affect. Prog Brain Res 156: 235-247.
2. Grandjean D, Sander D, Pourtois G, Schwartz S, Seghier ML, et al. (2005) The voices of wrath: brain responses to angry prosody in meaningless speech. Nat Neurosci 8: 145-146. (Pubitemid 40194042)
3. Sander D, Grandjean D, Pourtois G, Schwartz S, Seghier ML, et al. (2005) Emotion and attention interactions in social cognition: brain regions involved in processing anger prosody. Neuroimage 28: 848-858. (Pubitemid 41713620)
4. Kotz SA, Schwartze M (2010) Cortical speech processing unplugged: a timely subcortico-cortical framework. Trends Cogn Sci 14: 392-399.
5. Fruhholz S, Ceravolo L, Grandjean D (2012) Specific Brain Networks during Explicit and Implicit Decoding of Emotional Prosody. Cereb Cortex 22: 1107-1117.
6. Péron J, Grandjean D, Le Jeune F, Sauleau P, Haegelen C, et al. (2010) Recognition of emotional prosody is altered after subthalamic nucleus deep brain stimulation in Parkinson's disease. Neuropsychologia 48: 1053-1062.
7. Péron J, Frühholz S, Vérin M, Grandjean D (2013) Subthalamic nucleus: A key structure for emotional component synchronization in humans. Neurosci Biobehav Rev 37: 358-373.
8. Gray HM, Tickle-Degnen L (2010) A meta-analysis of performance on emotion recognition tasks in Parkinson's disease. Neuropsychology 24: 176-191.
9. Péron J, Dondaine T, Le Jeune F, Grandjean D, Verin M (2012) Emotional processing in Parkinson's disease: a systematic review. Mov Disord 27: 186-199.
10. MacDonald AA, Monchi O, Seergobin KN, Ganjavi H, Tamjeedi R, et al. (2013) Parkinson's disease duration determines effect of dopaminergic therapy on ventral striatum function. Mov Disord 28: 153-160.
11. Cools R, Barker RA, Sahakian BJ, Robbins TW (2001) Enhanced or impaired cognitive function in Parkinson's disease as a function of dopaminergic medication and task demands. Cereb Cortex 11: 1136-1143. (Pubitemid 33108240)
12. MacDonald PA, MacDonald AA, Seergobin KN, Tamjeedi R, Ganjavi H, et al. (2011) The effect of dopamine therapy on ventral and dorsal striatum-mediated cognition in Parkinson's disease: support from functional MRI. Brain 134: 1447-1463.
13. Macdonald PA, Monchi O (2011) Differential effects of dopaminergic therapies on dorsal and ventral striatum in Parkinson's disease: implications for cognitive function. Parkinsons Dis 2011: 572743.
14. Cools R, Lewis SJ, Clark L, Barker RA, Robbins TW (2007) L-DOPA disrupts activity in the nucleus accumbens during reversal learning in Parkinson's disease. Neuropsychopharmacology 32: 180-189. (Pubitemid 44967796)
15. Swainson R, Rogers RD, Sahakian BJ, Summers BA, Polkey CE, et al. (2000) Probabilistic learning and reversal deficits in patients with Parkinson's disease or frontal or temporal lobe lesions: possible adverse effects of dopaminergic medication. Neuropsychologia 38: 596-612. (Pubitemid 30109440)
16. Breitenstein C, Van Lancker D, Daum I, Waters CH (2001) Impaired perception of vocal emotions in Parkinson's disease: influence of speech time processing and executive functioning. Brain Cogn 45: 277-314. (Pubitemid 32216120)
17. Hughes AJ, Daniel SE, Kilford L, Lees AJ (1992) Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 55: 181-184.
18. Hoehn MM, Yahr MD (1967) Parkinsonism: onset, progression and mortality. Neurology 17: 427-442.
19. Schwab R, England A (1969) Projection techniques for evaluating surgery in Parkinson's Disease.; 1969; Royal College of Surgeons in Edinburgh. E & S Livingstone Ltd. pp. 152-157.
20. Tomlinson CL, Stowe R, Patel S, Rick C, Gray R, et al. (2010) Systematic review of levodopa dose equivalency reporting in Parkinson's disease. Mov Disord 25: 2649-2653.
21. Gancher ST, Nutt JG, Woodward WR (1987) Peripheral pharmacokinetics of levodopa in untreated, stable, and fluctuating parkinsonian patients. Neurology 37: 940-944. (Pubitemid 17081066)
22. Kvernmo T, Hartter S, Burger E (2006) A review of the receptor-binding and pharmacokinetic properties of dopamine agonists. Clin Ther 28: 1065-1078. (Pubitemid 44374749)
23. Dérouesné C (2001) Echelles et classifications: le mini-mental state examination, version française consensuelle du GRECO. Revue Neurologique 157: 567-571.
24. Péron J, Biseul I, Leray E, Vicente S, Le Jeune F, et al. (2010) Subthalamic nucleus stimulation affects fear and sadness recognition in Parkinson's disease. Neuropsychology 24: 1-8.
25. Péron J, Le Jeune F, Haegelen C, Dondaine T, Drapier D, et al. (2010) Subthalamic nucleus stimulation affects theory of mind network: a PET study in Parkinson's disease. PLoS One 5: e9919.
26. Péron J, Vicente S, Leray E, Drapier S, Drapier D, et al. (2009) Are dopaminergic pathways involved in theory of mind? A study in Parkinson's disease. Neuropsychologia 47: 406-414.
27. Péron J, El Tamer S, Grandjean D, Leray E, Travers D, et al. (2011) Major depressive disorder skews the recognition of emotional prosody Progress in Neuro-Psychopharmacology and Biological Psychiatry 35: 987-996.
28. Mattis S (1988) Dementia rating scale. Ressources Inc Odessa, F.L: Psychological Assessment.
29. Nelson H (1976) A modified card sorting test sensitive to frontal lobe defects. Cortex 12: 313-324.
30. Reitan R (1958) Validity of the trail making test as an indication of organic brain damage. Percept Motor Skill 8: 271-276.
31. Cardebat D, Doyon B, Puel M, Goulet P, Joanette Y (1990) [Formal and semantic lexical evocation in normal subjects. Performance and dynamics of production as a function of sex, age and educational level]. Acta Neurol Belg 90: 207-217.
32. Woods SP, Scott JC, Sires DA, Grant I, Heaton RK, et al. (2005) Action (verb) fluency: test-retest reliability, normative standards, and construct validity. J Int Neuropsychol Soc 11: 408-415. (Pubitemid 41167178)
33. Stroop J (1935) Studies of interference in serial verbal reactions. Journal of Experimental Psychology 18: 643-662.
34. Montgomery S, Asberg M (1979) A new depression scale designed to be sensitive to change. British Journal of Psychiatry 134: 382-389. (Pubitemid 9136500)
35. Spielberger CD, Gorsuch RL, Lushene R, Vagg PR, Jacobs GA (1993) Manuel de l'inventaire d'anxiété état-trait forme Y (STAI-Y). Paris: Editions du Centre de Psychologie Appliquée.
36. Belin P, Fillion-Bilodeau S, Gosselin F (2008) The Montreal Affective Voices: a validated set of nonverbal affect bursts for research on auditory affective processing. Behav Res Methods 40: 531-539.
37. Le Jeune F, Péron J, Biseul I, Fournier S, Sauleau P, et al. (2008) Subthalamic nucleus stimulation affects orbitofrontal cortex in facial emotion recognition: a PET study. Brain 131: 1599-1608. (Pubitemid 351806466)
38. Ferreri F, Agbokou C, Gauthier S (2006) Recognition and management of neuropsychiatric complications in Parkinson's disease. Cmaj 175: 1545-1552. (Pubitemid 44955118)
39. Welter ML, Houeto JL, Tezenas du Montcel S, Mesnage V, Bonnet AM, et al. (2002) Clinical predictive factors of subthalamic stimulation in Parkinson's disease. Brain 125: 575-583. (Pubitemid 34194412)
40. Paulmann S, Pell MD, Kotz SA (2009) Comparative processing of emotional prosody and semantics following basal ganglia infarcts: ERP evidence of selective impairments for disgust and fear. Brain Res 1295: 159-169.
41. Salgado-Pineda P, Delaveau P, Blin O, Nieoullon A (2005) Dopaminergic contribution to the regulation of emotional perception. Clin Neuropharmacol 28: 228-237. (Pubitemid 41579621)
42. Lawrence AD, Calder AJ, McGowan SW, Grasby PM (2002) Selective disruption of the recognition of facial expressions of anger. Neuroreport 13: 881-884. (Pubitemid 34492919)
43. Takahashi H, Yahata N, Koeda M, Takano A, Asai K, et al. (2005) Effects of dopaminergic and serotonergic manipulation on emotional processing: a pharmacological fMRI study. Neuroimage 27: 991-1001. (Pubitemid 41317266)
44. Hariri AR, Mattay VS, Tessitore A, Fera F, Smith WG, et al. (2002) Dextroamphetamine modulates the response of the human amygdala. Neuropsychopharmacology 27: 1036-1040. (Pubitemid 35447640)
45. Delaveau P, Salgado-Pineda P, Wicker B, Micallef-Roll J, Blin O (2005) Effect of levodopa on healthy volunteers' facial emotion perception: an FMRI study. Clin Neuropharmacol 28: 255-261. (Pubitemid 44378613)
46. Schultz W (2013) Updating dopamine reward signals. Curr Opin Neurobiol 23: 229-238.
47. Baik JH (2013) Dopamine Signaling in reward-related behaviors. Front Neural Circuits 7: 152.
48. Uhl GR, Hedreen JC, Price DL (1985) Parkinson's disease: loss of neurons from the ventral tegmental area contralateral to therapeutic surgical lesions. Neurology 35: 1215-1218. (Pubitemid 15003464)